CDK4 and colorectal carcinoma: In patients with CRC, supplementation with RS for up to 4 wk reduced the proportion of mitotic cells in the upper half of colonic crypts, a marker of crypt health, and positively influenced the expression of 2 cell cycle regulators, CDK4 and GADD45A, providing evidence for antineoplastic effects of RS (20).